Abstract
Background
Whether 7,8-dihydroxyflavone (7,8-DHF), a tyrosine kinase receptor B (TrkB) agonist, modulates colonic smooth muscle motility and/or alleviates constipation has not yet been studied.
Aims
Here, we aimed to determine how 7,8-DHF influences carbachol (CCh)-stimulated contraction of colonic strips and the in vivo effect of 7,8-DHF on constipation.
Methods
Muscle strips were isolated from rat colons for recording contractile tension and performing western blotting. Constipation was induced in rats with loperamide.
Results
Although it specifically activated TrkB, 7,8-DHF applied alone neither activated PLCγ1 in the colonic strips nor induced colonic strip contraction. However, 7,8-DHF enhanced CCh-stimulated PLCγ1 activation and strip contraction. The PLCγ1 antagonist U73122 suppressed both CCh-stimulated and 7,8-DHF-enhanced/CCh-stimulated contraction. While clarifying the underlying mechanism, we revealed that 7,8-DHF augmented muscarinic M3 receptor expression in the colonic strips. The M3-selective antagonist tarafenacin specifically inhibited the 7,8-DHF-enhanced/CCh-stimulated contraction of the colonic strips. Since 7,8-DHF increased Akt phosphorylation, and LY294002 (an antagonist of PI3K upstream of Akt) dramatically inhibited both 7,8-DHF-augmented M3 expression and 7,8-DHF-enhanced/CCh-stimulated contractions, we assumed that 7,8-DHF/TrkB/Akt was associated with the modulation of M3 expression in the colonic strips. ANA-12, a specific TrkB antagonist, not only inhibited TrkB activation by 7,8-DHF but also suppressed 7,8-DHF-enhanced cholinergic contraction, 7,8-DHF/CCh-mediated activation of PLCγ1/Akt, and M3 overexpression in colonic strips. In vivo 7,8-DHF, also by promoting intestinal motility and M3 expression, significantly alleviated loperamide-induced functional constipation in rats.
Conclusions
Our results suggest that 7,8-DHF regulates colonic motility possibly via a TrkB/Akt/M3 pathway and may be applicable for alleviating constipation.
Similar content being viewed by others
References
Bharucha AE and Wald A. Chronic Constipation. Mayo Clin Proc. 2019. pii: S0025–6196-30123–5.
Tejeda GS and Díaz-Guerra M. Integral Characterization of Defective BDNF/TrkB Signaling in Neurological and Psychiatric Disorders Leads the Way to New Therapies. Int J Mol Sci. 2017;18: E268.
Waterhouse EG, Xu B. New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci. 2009;42:81–89
Chen F, Yu Y, Wang P, Dong Y, Wang T, Zuo X, Li Y. Brain-derived neurotrophic factor accelerates gut motility in slow-transit constipation. Acta Physiologica 2014;212:226–238
Chai NL, Dong L, Li ZF, Du KX, Wang JH, Yan LK, Dong XL. Effects of neurotrophins on gastrointestinal myoelectric activities of rats. World J Gastroenterol. 2003;9:1874–1877
Liu C, Chan CB, Ye K. 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Transl Neurodegener. 2016;6:2
Sim DY, Sohng JK, Jung HJ. Anticancer activity of 7,8-dihydroxyflavone in melanoma cells via downregulation of α-MSH/cAMP/MITF pathway. Oncol Rep. 2016;36:528–534
Chan CB, Tse MC, Liu X, Zhang S, Schmidt R, Otten R, Liu L, Ye K. Activation of muscular TrkB by its small molecular agonist 7,8-dihydroxyflavone sex-dependently regulates energy metabolism in diet-induced obese mice. Chem Biol. 2015;22:355–368
Cho SJ, Kang KA, Piao MJ et al. 7,8-Dihydroxyflavone Protects High Glucose-Damaged Neuronal Cells against Oxidative Stress. Biomol Ther (Seoul). 2019;27:85–91
Zhao J, Du J, Pan Y et al. Activation of cardiac TrkB receptor by its small molecular agonist 7,8-dihydroxyflavone inhibits doxorubicin-induced cardiotoxicity via enhancing mitochondrial oxidative phosphorylation. Free Radic Biol Med. 2019;130:557–567
Huai R, Han X, Wang B, Li C, Niu Y, Li R, Qu Z. Vasorelaxing and Antihypertensive Effects of 7,8-Dihydroxyflavone. Am J Hypert. 2014;27:750–760
He B, Qu Z, Tian Z et al. 7,8-dihydroxyflavone enhanced cholinergic contraction of rat gastric smooth muscle via augmenting muscarinic M3 receptor expression. Clin Exp Pharmacol Physiol. 2018;45:1170–1180
Ma L, Qu Z, Luan X, et al. Effects of 7,8-Dihydroxyflavone on Rat Jejunal Dynamics Subjected to Ischemia-Reperfusion Injury Clin Exp Pharmacol Physiol. 2020; 47:67–75.
Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE, Ye K. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci USA 2010;107:2687–2692
Du X, Hill RA. 7,8-Dihydroxyflavone as a proneurotrophic treatment for neurodevelopmental disorders. Neurochemistry International. 2015;89:170–180
Al-Qudah M, Anderson CD, Mahavadi S, Bradley ZL, Akbarali HI, Murthy KS, Grider JR. Brain-derived neurotrophic factor enhances cholinergic contraction of longitudinal muscle of rabbit intestine via activation of phospholipase C. Am J Physiol Gastrointest Liver Physiol 2014;306:G328–G337
Chen F, Yu Y, Yuan X, Zuo L and Li Y. Brain-derived neurotrophic factor enhances the contraction of intestinal muscle strips induced by SP and CGRP in mice. Regul Pept. 2012;178:86–94.
Luan X, Sun X, Guo F, Zhang D, Wang C, Ma L, Xu L. Lateral hypothalamic Orexin-A-ergic projections to the arcuate nucleus modulate gastric function in vivo. J Neurochem. 2017;143:697–707.
Wintola OA, Sunmonu TO and Afolayan AJ. The effect of Aloe ferox Mill. in the treatment of loperamide-induced constipation in Wistar rats. BMC Gastroenterol. 2010; 10:95.
Zholos AV. Regulation of TRP-like muscarinic cation current in gastrointestinal smooth muscle with special reference to PLC/InsP3/Ca2+ system. Acta Pharmacologica Sinica 2006;27:833–842
Tobin G, Giglio D, Lundgren O. Muscarinic receptor subtypes in the alimentary tract. J Physiol Pharmacol. 2009;60:3–21
Harrington AM, Peck CJ, Liu L, Burcher E, Hutson JM and Southwell BR. Localization of muscarinic receptors M1R, M2R and M3R in the human colon. Neurogastroenterol Motil. 2010; 22:999–1008, e262–3.
Bhattacharya S, Mahavadi S, Al-Shboul O, Rajagopal S, Grider JR, Murthy KS. Differential regulation of muscarinic M2 and M3 receptor signaling in gastrointestinal smooth muscle by caveolin-1. Am J Physiol Cell Physiol 2013;305:C334–C347
Zenko D, Hislop JN. Regulation and trafficking of muscarinic acetylcholine receptors. Neuropharmacology. 2018;136:374–382
Wang B, Li C, Huai R, Qu Z. Overexpression of ANO1/TMEM16A, an arterial Ca2+-activated Cl- channel, contributes to spontaneous hypertension. J Mol Cell Cardiol 2015;82:22–32
Ehlert FJ, Pak KJ, Griffin MT. Muscarinic agonists and antagonists: effects on gastrointestinal function. Handb Exp Pharmacol 2012;208:343–374
Sheffler DJ, Williams R, Bridges TM, Xiang Z, Kane AS, Byun NE, Jadhav S, Mock MM, Zheng F, Lewis LM, Jones CK, Niswender CM, Weaver CD, Lindsley CW, Conn PJ. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduced seizures without impairing hippocampus-dependent learning. Mol Pharmacol. 2009;76:356–368
Gitler MS, Boulay SF, Sood VK, McPherson DW, Knap FF Jr, Zeeberg BR, Reba RC. Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (R, S)-[125I]IQNB. Brain Res. 1995;687:71–78
Haga K, Kruse AC, Asada H, Yurugi-Kobayashi T, Shiroishi M, Zhang C, Weis WI, Okada T, Kobilka BK, Haga T, Kobayashi T. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature. 2012;482:547–551
Salcedo C, Davalillo S, Cabellos J, Lagunas C, Balsa D, Pérez-Del-Pulgar S, Ballarín M, Fernández A. In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder. Br J Pharmacol. 2009;156:807–817
Hanauer SB. The role of loperamide in gastrointestinal disorders. Rev Gastroenterol Disord. 2008;8:15–20
Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N, Cedarbaum JM. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology 2000;119:41–50
Liu X, Obianyo O, Chan CB, Huang J, Xue S, Yang JJ, Zeng F, Goodman M, Ye K. Biochemical and Biophysical Investigation of the Brain-derived Neurotrophic Factor Mimetic 7,8-Dihydroxyflavone in the Binding and Activation of the TrkB Receptor. J Bio Chem 2014;289:27571–27584
Acknowledgments
This study was supported by the National Natural Science Foundation of China (NSFC 31371152 to ZQ, 81500414 to LX, and 81500363 to BW) and the Qingdao University Award for the Excellence of Young Physicians to BH. We would like to thank American Journal Experts (www.aje.com) for English language editing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ma, L., Qu, Z., Xu, L. et al. 7,8-Dihydroxyflavone Enhanced Colonic Cholinergic Contraction and Relieved Loperamide-Induced Constipation in Rats. Dig Dis Sci 66, 4251–4262 (2021). https://doi.org/10.1007/s10620-020-06817-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-020-06817-y